Elevated serum inflammatory biomarkers including C-reactive protein (CRP), IL-6, and serum amyloid A (SAA) were positively associated with an increased risk of recurrence of HR+/HER2- tumor, and higher CRP level was correlated with detectable serum estrogen metabolites [108]. This evidence concerns the gene CRP and neoplasm.